Flowmetric Life Sciences, Inc. provides Flow Cytometry Solutions in Precision Medicine. The company was founded by Renold Capocasale and is headquartered in Doylestown, PA.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

PANAGENE Inc. engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips. The firm operates through the PNA Materials and Diagnostic Product business divisions. Its products are marketed as PANAMutyper, PNAClamp, PANArray, PANA qPCR, PNA Oligo and Monomer. The company was founded on April 16, 2001 and is headquartered in Daejeon, South Korea.

Chongqing Dongdeng Technology Co., Ltd., established on 2006-10-11, Business scope includes licensed projects:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Mechanical equipment research and development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technology Import and Export;Import and export;Auto New Car Sales;Sales of new energy vehicles;Special Equipment Sales;Engineering and Technology Research and Experimental Development;Optoelectronic products,photoelectric sensor,Instrumentation,Research and development of automatic control integrated system and spare parts,Production(Limited to branch operations),Sales,repair,Technical Services for Medical Devices,repair,Sell ​​outdoor products,household appliances,Emergency Rescue Equipment,engineering vehicle,Computer software and hardware products,Network equipment,communication device(Does not include satellite ground receiving equipment).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kyoritsu Seiyaku Corp. engages in the research, development, and production of vaccines and drugs for pets, livestock, and marine animals. It also deals with the manufacture of industrial and general deodorizers. The company was founded on May 19, 1955 and is headquartered in Tokyo, Japan.

Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

Interway International Ltd. is a private company headquartered in Hong Kong, Hong Kong, that manufactures and distributes chemicals. Sufan Siauw is the current CEO of the firm.

LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. Its products include sample and bioinformatics analysis, diagnostic checks, and other products. The company was founded on March 29, 2002 and is headquartered in Seongnam-si, South Korea.

Rongzhi Fengsheng Pharmaceutical Co., Ltd., established on 2011-05-20, The business scope includes the production of small-volume injections,Drug R&D and Technology Transfer,Technical Services;Acquisition of agricultural and sideline products,processing,Sales;Cosmetic production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Huzhou Shukang Biotechnology Co., Ltd., established on 2001-02-09, Business scope includes general items:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Sales of Class II Medical Devices;Class II Medical Device Leasing;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Fresh milk road transport(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Chengdu Xintong Wangyi Medical Sci & Tech Devt Co., Ltd. engages in the research and development, design and installation of medical and health information management system. The company was founded in 1993 and is headquartered in Chengdu, China.

SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.

Shanghai Shukang Biotechnology Co., Ltd., established on 2000-10-20, Business scope includes new medicine,traditional Chinese medicine,Medical Diagnostic Technology,Biotechnology,Research and development of biochip and its supporting products,Transfer of self-research results,And provide related technical consulting services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]